8 insights on how employee benefits consultants can help address obesity in the workplace  

1440x700_White_Paper_Obesity_Bias

As GLP-1 medications gain traction for weight loss and chronic disease management, employers face complex decisions regarding coverage, cost control, and long-term outcomes. Wondr Health’s latest playbook offers the following insights and more on how to help your clients optimize employee health while managing financial risks:  Obesity and weight-related chronic conditions are growing workplace challenges, […]

The past, present and future of GLP-1s 

By The Wondr Health Team  Obesity and weight-related chronic conditions are one of the most pressing challenges in the modern workplace. Half of American adults have at least one chronic condition and 90% of the U.S. medical expenditures are associated with chronic and mental health conditions. Rising obesity rates and increased healthcare spending also contribute […]

6 top weight-loss medication misconceptions 

If you’re aiming to improve the health of your people, it’s time to reframe the conversation about weight-loss medications. There is a lot of misinformation surrounding these medications – on social, in the news, and more. This blog serves as a roadmap for employers like you, eager to elevate the well-being of your population. So, […]

The top 3 transformative workplace wellness trends of the year

In 2024, we saw many important health-care developments that are shifting workplace wellness trends, including breakthroughs in GLP-1 weight-loss medications, an increased focus on mental health and stress management in the workplace, and an increasing demand for tailored wellness solutions. With rising rates of chronic disease and related health-care costs, organizations are using tactics such […]

The Case for Physical Activity with GLP-1 Coverage 

Employers are feeling the pressure due to rising health-care costs – and with good reason. With obesity rates rising and prescription expenses growing, health-care costs are expected to grow by 8% next year. Meanwhile, an immense spotlight has been on GLP-1 medications – with employees wanting to lose weight and employers wanting to reduce the […]

5 Eye-opening Weight Bias Misconceptions That Fuel Misinformation

With growing attention on obesity medicine, we’ve seen an increase in weight-loss misconceptions—particularly around GLP-1 medications. As leaders in health, it’s our responsibility to address these myths with clear, science-backed information that prioritizes the well-being of those we serve. At Wondr Health, we are committed to educating about obesity medicine and helping remove weight bias […]

Navigating challenges with weight-loss medications within your benefit strategy 

While GLP-1s are a hot topic and touted as the cure to weight loss, there are many factors that employers need to consider, such as medication adherence, clinical results, and ROI.  To navigate potential obstacles with weight-loss medications, Wondr Health surveyed participants in June and asked them to multi-select which factors are top on their […]

Entering an era of breakthrough results for obesity and depression 

As May is World Mental Health Awareness Month, many of us in the medical profession take the time to reflect on the impact of mental health in our communities and organizations.   It’s no secret that depression is a common disorder that affects mental health, but its bidirectional relationship with obesity often goes unrecognized. Studies […]

EXCLUSIVE: Addressing three major GLP-1 myths 

1440x700_Blog_IMage_04_11_2024-1

The latest frenzy in the world of weight-loss is undoubtedly weight-loss medications. But, what we know about the efficacy and suggested use of these medications is very different from what is portrayed in the media.  So, let’s set the record straight.   MYTH 1: Quick fix for weight loss  If anything promises to be a ‘miracle […]